Developing innovative treatments designed to improve the everyday lives of women and men
Driving Innovative Research
We aim to develop a targeted approach for diseases of high unmet medical need. Our team is committed to bringing much-needed attention and innovation to women’s health and prostate cancer.
– Lynn Seely, MD, President and Chief Executive Officer
For too long, patients have suffered in the shadows. We are bringing this issue to the light and fighting for a brighter future."
24 May 2019
Myovant Sciences Provides Corporate Updates and Reports Financial Results for Fourth Fiscal Quarter and Full Fiscal Year Ended March 31, 2019